Cash flow Perspective Therapeutics, Inc.

Stocks

CATX

US46489V3024

Biotechnology & Medical Research

Market Closed - NYSE Other stock markets 00:00:00 30/06/2026 +04			5-day change	1st Jan Change
3.550 ^USD	+16.78%		+20.34%	+29.09%

06-03	Perspective Therapeutics Doses First Meningioma Patient in Phase 1/2a Study Cohort	MT
06-03	Perspective Therapeutics Doses First Patient with [212Pb]Vmt-?-Net in Meningioma Cohort of Phase 1/2A Study	CI

b6f4267329817f6.ToelsvhN0pVJ5aAIprAN7B0wUMDn9PUkYC7JgtuzjYA.Ddad9pcsgtEag5VN7fFHjk9CCfKkwoByM2Oj0aHr4bZj5d_QlAW6rRqd4Q

Published financial data: PERSPECTIVE THERAPEUTICS, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	10.05M	7.1M	1.43M	1.45M	884K
Total Revenues	10.05M	7.1M	1.43M	1.45M	884K
Cost of Goods Sold, Total	4.93M	5.47M	-	39.43M	84.22M
Gross Profit	5.12M	1.63M	1.43M	-37.98M	-83.33M
Selling General & Admin Expenses, Total	7.13M	14.21M	21.06M	26.61M	30.23M
R&D Expenses	1.43M	2.6M	21.31M	2.21M	-
Other Operating Expenses	-	-	-	-	-
Other Operating Expenses, Total	8.56M	16.82M	42.38M	28.82M	30.23M
Operating Income	-3.44M	-15.18M	-40.94M	-66.8M	-114M
Interest Expense, Total	-	-	-84K	-48K	-376K
Interest And Investment Income	59K	1.12M	934K	10.52M	8.11M
Net Interest Expenses	59K	1.12M	850K	10.47M	7.74M
Income (Loss) On Equity Invest.	-	-	-17K	-8K	-2K
Other Non Operating Income (Expenses)	-	-	2K	-	1.4M
EBT, Excl. Unusual Items	-3.38M	-14.06M	-40.11M	-56.34M	-104M
Restructuring Charges	-	-	-	-	-
Impairment of Goodwill	-	-	-	-24.06M	-
Gain (Loss) On Sale Of Assets	-9K	-610K	-	-27K	-
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	-3.39M	-14.67M	-40.11M	-80.43M	-104M
Income Tax Expense	-	-	-2.65M	-2.1M	-793K
Earnings From Continuing Operations	-3.39M	-14.67M	-37.46M	-78.33M	-104M
Earnings Of Discontinued Operations	-	-	-9.05M	-949K	514K
Net Income to Company	-3.39M	-14.67M	-46.51M	-79.28M	-103M
Net Income - (IS)	-3.39M	-14.67M	-46.51M	-79.28M	-103M
Preferred Dividend and Other Adjustments	3K	-	-	-	-
Net Income to Common Incl Extra Items	-3.39M	-14.67M	-46.51M	-79.28M	-103M
Net Income to Common Excl. Extra Items	-3.39M	-14.67M	-37.46M	-78.33M	-104M
Per Share Items
Net EPS - Basic	-0.33	-1.03	-1.74	-1.23	-1.4
Basic EPS - Continuing Operations	-0.33	-1.03	-1.4	-1.22	-1.4
Basic Weighted Average Shares Outstanding	10.38M	14.21M	26.76M	64.42M	73.81M
Net EPS - Diluted	-0.33	-1.03	-1.74	-1.23	-1.4
Diluted EPS - Continuing Operations	-0.33	-1.03	-1.4	-1.22	-1.4
Diluted Weighted Average Shares Outstanding	10.38M	14.21M	26.76M	64.42M	73.81M
Normalized Basic EPS	-0.2	-0.62	-0.94	-0.55	-0.88
Normalized Diluted EPS	-0.2	-0.62	-0.94	-0.55	-0.88
Payout Ratio	-0.27	-	-	-	-
Supplemental Items
EBITDA	-3.23M	-14.84M	-39.96M	-64.5M	-110M
EBITA	-3.38M	-15.11M	-40.91M	-66.8M	-114M
EBIT	-3.44M	-15.18M	-40.94M	-66.8M	-114M
EBITDAR	-2.92M	-7.26M	-39.86M	-63.7M	-109M
Effective Tax Rate - (Ratio)	-	-	6.61	2.61	0.76
Deferred Domestic Taxes	-	-	-2.65M	-2.1M	-793K
Total Deferred Taxes	-	-	-2.65M	-2.1M	-793K
Normalized Net Income	-2.11M	-8.79M	-25.07M	-35.21M	-65.27M
Interest on Long-Term Debt	-	-	84K	-	-
Supplemental Operating Expense Items
Marketing Expenses	84K	126K	-	-	-
Selling and Marketing Expenses	2.44M	3.23M	-	-	-
General and Administrative Expenses	4.58M	10.87M	20.97M	25.81M	29.13M
Research And Development Expense From Footnotes	1.43M	2.6M	21.31M	41.64M	84.22M
Net Rental Expense, Total	304K	161K	97K	800K	1.1M
Imputed Operating Lease Interest Expense	-	-	-	92.9K	905K
Imputed Operating Lease Depreciation	-	-	-	707K	195K
Stock-Based Comp., COGS (Total)	30K	28K	-	-	3.94M
Stock-Based Comp., R&D Exp. (Total)	104K	316K	968K	2.21M	-
Stock-Based Comp., S&M Exp. (Total)	49K	94K	-	-	-
Stock-Based Comp., G&A Exp. (Total)	203K	906K	2.18M	3.01M	5.02M
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	386K	1.34M	3.14M	5.22M	8.97M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	63.83M	20.99M	9.24M	61.58M	30.63M
Short Term Investments	-	22.76M	-	165M	114M
Total Cash And Short Term Investments	63.83M	43.76M	9.24M	227M	145M
Accounts Receivable, Total	2.01M	1.36M	1.16M	116K	6K
Other Receivables	32K	2K	10K	1.37M	1.03M
Notes Receivable	-	6.11M	-	-	-
Total Receivables	2.04M	7.47M	1.18M	1.48M	1.04M
Inventory	980K	1.41M	-	-	-
Prepaid Expenses	422K	548K	1.08M	2.68M	2.58M
Other Current Assets, Total	27K	27K	5.35M	81K	35K
Total Current Assets	67.3M	53.22M	16.84M	231M	148M
Gross Property Plant And Equipment	9.97M	9.69M	6.99M	62.5M	84.3M
Accumulated Depreciation	-7.25M	-7.63M	-669K	-2.96M	-6.2M
Net Property Plant And Equipment	2.73M	2.06M	6.32M	59.54M	78.1M
Long-term Investments	-	150K	133K	126K	124K
Goodwill	-	-	24.06M	-	-
Other Intangibles, Total	130K	86K	50.35M	50.01M	40M
Other Long-Term Assets, Total	258K	2.58M	182K	268K	358K
Total Assets	70.42M	58.09M	97.89M	341M	267M
Liabilities
Accounts Payable, Total	730K	1.54M	6.11M	9.84M	20.31M
Accrued Expenses, Total	819K	859K	4.39M	5.48M	7.49M
Current Portion of Long-Term Debt	-	-	49K	52K	56K
Current Portion of Leases	252K	276K	46K	957K	623K
Unearned Revenue Current, Total	-	-	-	1.4M	-
Other Current Liabilities	-	-	5.07M	500K	200K
Total Current Liabilities	1.8M	2.68M	15.66M	18.23M	28.68M
Long-Term Debt	-	-	1.68M	1.62M	1.57M
Long-Term Leases	524K	116K	780K	1.43M	1M
Unearned Revenue Non Current	-	-	-	26.6M	26.6M
Deferred Tax Liability Non Current	-	-	4.59M	2.5M	1.7M
Other Non Current Liabilities	685K	657K	-	55K	386K
Total Liabilities	3.01M	3.45M	22.71M	50.43M	59.94M
Preferred Stock Convertible	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	142K	142K	282K	70K	74K
Additional Paid In Capital	159M	160M	227M	522M	542M
Retained Earnings	-91.32M	-106M	-152M	-232M	-335M
Comprehensive Income and Other	-	-	-	-51K	110K
Total Common Equity	67.41M	54.64M	75.18M	291M	207M
Total Equity	67.41M	54.64M	75.18M	291M	207M
Total Liabilities And Equity	70.42M	58.09M	97.89M	341M	267M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	14.19M	28M	58.69M	74.05M	114M
ECS Total Common Shares Outstanding	14.19M	14.21M	28.18M	70.67M	74.34M
Book Value / Share	4.75	3.84	2.67	4.11	2.78
Tangible Book Value	67.28M	54.56M	763K	241M	167M
Tangible Book Value Per Share	4.74	3.84	0.03	3.41	2.25
Total Debt	776K	392K	2.55M	4.06M	3.25M
Net Debt	-63.05M	-43.36M	-6.69M	-223M	-141M
Debt Equivalent Oper. Leases	2.43M	2.5M	776K	6.4M	8.8M
Equity Method Investments, Total	-	150K	133K	126K	124K
Account Code - Inventory Valuation	6	6	6	6	3
Inventories - Raw Materials, Total	645K	752K	-	-	-
Inventories - Work In Process, Total	286K	636K	-	-	-
Inventories - Finished Goods, Total	49K	21K	-	-	-
Land - (BS)	366K	366K	1.28M	917K	917K
Buildings, Total	-	-	1.77M	1.77M	1.77M
Machinery, Total	4.2M	4.58M	2.68M	11.42M	15.46M
Full Time Employees	61	66	116	138	163
Part Time Employees	-	-	3	2	3
Accumulated Allowance for Doubtful Accounts (Supple)	26K	26K	650K	543K	375K

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-3.39M	-14.67M	-46.51M	-79.28M	-103M
Depreciation & Amortization - CF	149K	276K	946K	2.3M	3.24M
Amortization of Goodwill and Intangible Assets - (CF)	61K	68K	35K	-	-
Depreciation & Amortization, Total	210K	344K	981K	2.3M	3.24M
Amortization of Deferred Charges, Total - (CF)	7K	8K	7K	7K	7K
(Gain) Loss From Sale Of Asset	10K	610K	22K	27K	-
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-607K	-2.72M
Asset Writedown & Restructuring Costs	-	-	-	24.06M	-
(Income) Loss On Equity Investments - (CF)	-	-	17K	-	-
Stock-Based Compensation (CF)	386K	1.34M	3.74M	5.22M	8.97M
Provision and Write-off of Bad Debts	-	-	624K	-	-
Net Cash From Discontinued Operations	-	-	33K	236K	-
Other Operating Activities, Total	4K	-448K	1.88M	-2.06M	9.46M
Change In Accounts Receivable	31K	490K	-426K	1.05M	110K
Change In Inventories	-274K	-152K	359K	-	-
Change In Accounts Payable	76K	1.15M	1.58M	1.89M	147K
Change in Unearned Revenues	-	-	-	28M	-1.4M
Change in Other Net Operating Assets	100K	-844K	779K	864K	2.82M
Cash from Operations	-2.84M	-12.17M	-36.91M	-18.29M	-82.48M
Capital Expenditure	-381K	-302K	-1.07M	-54.41M	-12.75M
Sale of Property, Plant, and Equipment	1K	-	-	335K	-
Cash Acquisitions	-	-	2.7M	-	-
Sale (Purchase) of Intangible assets	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-	-45.38M	22.76M	-165M	54.11M
Other Investing Activities, Total	-30K	-12M	-18K	-72K	-135K
Cash from Investing	-410K	-57.68M	24.37M	-219M	41.23M
Long-Term Debt Repaid, Total	-	-	-68K	-48K	-52K
Total Debt Repaid	-	-	-68K	-48K	-52K
Issuance of Common Stock	64.69M	56K	554K	277M	10.36M
Preferred Dividends Paid	-9K	-	-	-	-
Common & Preferred Stock Dividends Paid	-9K	-	-	-	-
Other Financing Activities, Total	-	-	299K	12.25M	-
Cash from Financing	64.68M	56K	785K	289M	10.3M
Net Change in Cash	61.44M	-69.79M	-11.76M	52.16M	-30.95M
Supplemental Items
Cash Interest Paid	-	-	84K	-	-
Levered Free Cash Flow	-2.08M	-2.99M	-8.27M	-83.66M	-60.37M
Unlevered Free Cash Flow	-2.08M	-2.99M	-8.22M	-83.63M	-60.14M
Change In Net Working Capital	149K	-484K	-14.31M	-5.01M	-11.37M
Net Debt Issued / Repaid	-	-	-68K	-48K	-52K

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-5.43	-6.85	-32.81	-19.02	-23.34
Return on Total Capital	-5.74	-7.11	-38.66	-22.42	-28.11
Return On Equity %	-9.26	-11.3	-57.7	-42.82	-41.65
Return on Common Equity	-9.27	-11.3	-57.7	-42.82	-41.65
Margin Analysis
Gross Profit Margin %	50.94	23	100	-2.61K	-9.43K
SG&A Margin	70.93	200.08	1.47K	1.83K	3.42K
EBITDA Margin %	-32.1	-208.87	-2.79K	-4.44K	-12.48K
EBITA Margin %	-33.58	-212.75	-2.85K	-4.59K	-12.85K
EBIT Margin %	-34.19	-213.71	-2.86K	-4.59K	-12.85K
Income From Continuing Operations Margin %	-33.69	-206.5	-2.61K	-5.39K	-11.72K
Net Income Margin %	-33.69	-206.5	-3.24K	-5.45K	-11.67K
Net Avail. For Common Margin %	-33.72	-206.5	-2.61K	-5.39K	-11.72K
Normalized Net Income Margin	-21	-123.7	-1.75K	-2.42K	-7.38K
Levered Free Cash Flow Margin	-20.64	-27.73	-576.82	-5.75K	-6.83K
Unlevered Free Cash Flow Margin	-20.64	-27.73	-573.16	-5.75K	-6.8K
Asset Turnover
Asset Turnover	0.25	0.16	0.02	0.01	0
Fixed Assets Turnover	3.68	4.14	0.43	0.04	0.01
Receivables Turnover (Average Receivables)	4.96	5.96	1.13	2.27	14.49
Inventory Turnover (Average Inventory)	6.07	5.2	-	-	-
Short Term Liquidity
Current Ratio	37.37	19.89	1.07	12.68	5.17
Quick Ratio	36.58	16.86	0.66	12.53	5.08
Operating Cash Flow to Current Liabilities	-1.58	-4.55	-2.36	-1	-2.88
Days Sales Outstanding (Average Receivables)	73.65	61.22	321.73	161.23	25.19
Days Outstanding Inventory (Average Inventory)	60.13	70.18	-	-	-
Average Days Payable Outstanding	47.96	46.93	-	75.43	65.35
Cash Conversion Cycle (Average Days)	85.82	84.46	-	-	-
Long Term Solvency
Total Debt/Equity	1.15	0.72	3.39	1.4	1.57
Total Debt / Total Capital	1.14	0.71	3.28	1.38	1.55
LT Debt/Equity	0.78	0.21	3.27	1.05	1.24
Long-Term Debt / Total Capital	0.77	0.21	3.16	1.04	1.22
Total Liabilities / Total Assets	4.27	5.94	23.2	14.79	22.45
EBIT / Interest Expense	-	-	-487.39	-1.39K	-302.03
EBITDA / Interest Expense	-	-	-474.56	-1.33K	-290.48
(EBITDA - Capex) / Interest Expense	-	-	-487.32	-2.46K	-324.39
Total Debt / EBITDA	-0.27	-0.03	-0.06	-0.06	-0.03
Net Debt / EBITDA	21.57	2.92	0.17	3.5	1.3
Total Debt / (EBITDA - Capex)	-0.23	-0.03	-0.06	-0.03	-0.03
Net Debt / (EBITDA - Capex)	19.08	2.86	0.16	1.89	1.16
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	3.85	7.38	-73.52	1.39	-39.2
Gross Profit, 1 Yr. Growth %	-0.06	-9.86	-39.42	100.83	107.37
EBITDA, 1 Yr. Growth %	-1.32	119.31	371.34	60.34	71.04
EBITA, 1 Yr. Growth %	-1.2	116.97	367.76	63.15	70.01
EBIT, 1 Yr. Growth %	-1.12	115.04	365.34	63.15	70.01
Earnings From Cont. Operations, 1 Yr. Growth %	-1.71	114.7	341.43	109.13	32.31
Net Income, 1 Yr. Growth %	-1.71	114.7	332.23	70.46	30.07
Normalized Net Income, 1 Yr. Growth %	-1.97	115.28	390.29	40.47	85.36
Diluted EPS Before Extra, 1 Yr. Growth %	-36.16	56.88	134.32	-13.12	15.48
Accounts Receivable, 1 Yr. Growth %	-1.52	-20.12	-14.53	-90.04	-94.83
Inventory, 1 Yr. Growth %	51.94	42.45	-	-	-
Net Property, Plant and Equip., 1 Yr. Growth %	-0.37	-8.73	1.6K	841.58	31.18
Total Assets, 1 Yr. Growth %	709.47	-8.49	68.51	248.45	-21.73
Tangible Book Value, 1 Yr. Growth %	1.1K	-9.08	-98.6	31.44K	-30.6
Common Equity, 1 Yr. Growth %	1.08K	-9.09	37.58	286.63	-28.77
Cash From Operations, 1 Yr. Growth %	-22.08	171.77	254.9	-50.44	350.88
Capital Expenditures, 1 Yr. Growth %	39.56	-30.18	280.14	4.98K	-76.57
Levered Free Cash Flow, 1 Yr. Growth %	-21.53	44.25	-	879.9	-27.83
Unlevered Free Cash Flow, 1 Yr. Growth %	-21.53	44.25	-	885.47	-28.09
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	17.24	5.6	-	-48.18	-21.49
Gross Profit, 2 Yr. CAGR %	29.64	-5.09	-	300.54	109.93
EBITDA, 2 Yr. CAGR %	-20.26	47.11	-	175.82	65.6
EBITA, 2 Yr. CAGR %	-19.51	46.41	-	176.37	66.55
EBIT, 2 Yr. CAGR %	-19.3	45.82	-	175.54	66.55
Earnings From Cont. Operations, 2 Yr. CAGR %	-18.86	45.27	-	203.84	66.34
Net Income, 2 Yr. CAGR %	-18.86	45.27	-	171.44	48.91
Normalized Net Income, 2 Yr. CAGR %	-19.15	45.27	-	162.44	61.36
Diluted EPS Before Extra, 2 Yr. CAGR %	-34.84	0.08	-	42.68	0.16
Accounts Receivable, 2 Yr. CAGR %	32.07	-11.3	-	-70.83	-92.82
Inventory, 2 Yr. CAGR %	35.98	47.12	-	-	-
Net Property, Plant and Equip., 2 Yr. CAGR %	30.16	-4.64	-	1.17K	251.44
Total Assets, 2 Yr. CAGR %	173.38	172.17	-	142.32	65.14
Tangible Book Value, 2 Yr. CAGR %	199.14	230.95	-	109.91	1.38K
Common Equity, 2 Yr. CAGR %	196.26	227.22	-	130.64	65.95
Cash From Operations, 2 Yr. CAGR %	-25.04	45.52	-	32.62	49.48
Capital Expenditures, 2 Yr. CAGR %	-7.37	-1.29	-	1.29K	244.86
Levered Free Cash Flow, 2 Yr. CAGR %	-25.98	6.39	-	-	165.93
Unlevered Free Cash Flow, 2 Yr. CAGR %	-25.98	6.39	-	-	166.21
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	19.28	13.86	-	-	-45.35
Gross Profit, 3 Yr. CAGR %	40.61	14.85	-	-	227.74
EBITDA, 3 Yr. CAGR %	-21.16	11.72	-	-	135.21
EBITA, 3 Yr. CAGR %	-20.28	12.02	-	-	135.05
EBIT, 3 Yr. CAGR %	-20.06	11.88	-	-	134.58
Earnings From Cont. Operations, 3 Yr. CAGR %	-20.34	12.23	-	-	130.3
Net Income, 3 Yr. CAGR %	-20.34	12.23	-	-	112.41
Normalized Net Income, 3 Yr. CAGR %	-20.41	12.06	-	-	133.72
Diluted EPS Before Extra, 3 Yr. CAGR %	-35.5	-12.67	-	-	32.97
Accounts Receivable, 3 Yr. CAGR %	19.08	11.69	-	-	-83.61
Inventory, 3 Yr. CAGR %	25.65	38.1	-	-	-
Net Property, Plant and Equip., 3 Yr. CAGR %	27.64	15.64	-	-	494.87
Total Assets, 3 Yr. CAGR %	111.39	89.82	-	-	66.26
Tangible Book Value, 3 Yr. CAGR %	140.57	101.13	-	-	45.15
Common Equity, 3 Yr. CAGR %	137.53	99.82	-	-	55.9
Cash From Operations, 3 Yr. CAGR %	-20.81	15.16	-	-	99.42
Capital Expenditures, 3 Yr. CAGR %	4.18	-15.7	-	-	256.24
Levered Free Cash Flow, 3 Yr. CAGR %	-17.89	-7.55	-	-	-
Unlevered Free Cash Flow, 3 Yr. CAGR %	-17.89	-7.55	-	-	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	16.08	17.79	-	-	-
Gross Profit, 5 Yr. CAGR %	108.81	40.67	-	-	-
EBITDA, 5 Yr. CAGR %	-7.63	2.75	-	-	-
EBITA, 5 Yr. CAGR %	-8.52	3.24	-	-	-
EBIT, 5 Yr. CAGR %	-8.86	3.22	-	-	-
Earnings From Cont. Operations, 5 Yr. CAGR %	-6.39	3.37	-	-	-
Net Income, 5 Yr. CAGR %	-6.39	3.37	-	-	-
Normalized Net Income, 5 Yr. CAGR %	-7.89	3.36	-	-	-
Diluted EPS Before Extra, 5 Yr. CAGR %	-17.58	-14.52	-	-	-
Accounts Receivable, 5 Yr. CAGR %	27.18	17.24	-	-	-
Inventory, 5 Yr. CAGR %	24.02	34.01	-	-	-
Net Property, Plant and Equip., 5 Yr. CAGR %	36.42	18.74	-	-	-
Total Assets, 5 Yr. CAGR %	31.22	39.34	-	-	-
Tangible Book Value, 5 Yr. CAGR %	32.86	42.61	-	-	-
Common Equity, 5 Yr. CAGR %	32.67	42.03	-	-	-
Cash From Operations, 5 Yr. CAGR %	-6.09	6.18	-	-	-
Capital Expenditures, 5 Yr. CAGR %	-4.47	-13.49	-	-	-
Levered Free Cash Flow, 5 Yr. CAGR %	-3.22	-5.84	-	-	-
Unlevered Free Cash Flow, 5 Yr. CAGR %	-3.21	-5.84	-	-	-